Should You Buy Alibaba Stock Despite the Risks?
Markets rebounded slightly after U.S. President Donald Trump announced a…
Sell
30
PRCXF Quote, Financials, Valuation and Earnings
Last price:
$0.70
Seasonality move
:
--
Day range:
$0.70 - $0.70
52-week range:
$0.70 - $0.70
Dividend yield:
0%
P/E ratio:
13.94x
P/S ratio:
0.32x
P/B ratio:
1.02x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$100.5M
Revenue:
$307M
EPS (TTM):
$0.05
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
PRCXF
Green Cross Health
|
-- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
-- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge
|
-- | -- | -- | -- | -- |
|
RHCGF
Ryman Healthcare
|
-- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
PRCXF
Green Cross Health
|
$0.70 | -- | $100.5M | 13.94x | $0.01 | 0% | 0.32x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
$16.35 | -- | $9.6B | 62.70x | $0.11 | 1.54% | 8.96x |
|
PFGTF
Pacific Edge
|
$0.08 | -- | $64.1M | -- | $0.00 | 0% | 4.38x |
|
RHCGF
Ryman Healthcare
|
$1.41 | -- | $705M | -- | $0.00 | 0% | -- |
|
SMGRF
Summerset Group Holdings
|
$9.45 | -- | $2.3B | 11.05x | $0.08 | 1.55% | 11.74x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
PRCXF
Green Cross Health
|
47.81% | 0.000 | 83.12% | 0.44x |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
7.25% | 1.233 | 0.64% | 0.99x |
|
PFGTF
Pacific Edge
|
7.56% | -4.587 | 4.07% | 4.87x |
|
RHCGF
Ryman Healthcare
|
-- | -0.138 | -- | -- |
|
SMGRF
Summerset Group Holdings
|
36.6% | -0.028 | 43.27% | 0.11x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
PRCXF
Green Cross Health
|
-- | -- | 4.37% | 7.12% | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
-- | -- | 8.89% | 9.85% | -- | -- |
|
PFGTF
Pacific Edge
|
-- | -- | -54.77% | -56.46% | -- | -- |
|
RHCGF
Ryman Healthcare
|
-- | -- | -- | -- | -- | -- |
|
SMGRF
Summerset Group Holdings
|
-- | -- | 5.8% | 12.83% | -- | -- |
Green Cross Health vs. Competitors
-
Which has Higher Returns PRCXF or AROAF?
Aroa Biosurgery has a net margin of -- compared to Green Cross Health's net margin of --. Green Cross Health's return on equity of 7.12% beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PRCXFGreen Cross Health-- -- $198.2M AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About PRCXF or AROAF?
Green Cross Health has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Green Cross Health has higher upside potential than Aroa Biosurgery, analysts believe Green Cross Health is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings PRCXFGreen Cross Health0 0 0 AROAFAroa Biosurgery0 0 0 -
Is PRCXF or AROAF More Risky?
Green Cross Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock PRCXF or AROAF?
Green Cross Health has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Cross Health pays 441.92% of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCXF or AROAF?
Green Cross Health quarterly revenues are --, which are smaller than Aroa Biosurgery quarterly revenues of --. Green Cross Health's net income of -- is lower than Aroa Biosurgery's net income of --. Notably, Green Cross Health's price-to-earnings ratio is 13.94x while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Cross Health is 0.32x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCXFGreen Cross Health0.32x 13.94x -- -- AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns PRCXF or FSPKF?
Fisher & Paykel Healthcare has a net margin of -- compared to Green Cross Health's net margin of --. Green Cross Health's return on equity of 7.12% beat Fisher & Paykel Healthcare's return on equity of 9.85%.
Company Gross Margin Earnings Per Share Invested Capital PRCXFGreen Cross Health-- -- $198.2M FSPKFFisher & Paykel Healthcare-- -- $1.3B -
What do Analysts Say About PRCXF or FSPKF?
Green Cross Health has a consensus price target of --, signalling downside risk potential of --. On the other hand Fisher & Paykel Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Green Cross Health has higher upside potential than Fisher & Paykel Healthcare, analysts believe Green Cross Health is more attractive than Fisher & Paykel Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings PRCXFGreen Cross Health0 0 0 FSPKFFisher & Paykel Healthcare0 0 0 -
Is PRCXF or FSPKF More Risky?
Green Cross Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Fisher & Paykel Healthcare has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.655%.
-
Which is a Better Dividend Stock PRCXF or FSPKF?
Green Cross Health has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Fisher & Paykel Healthcare offers a yield of 1.54% to investors and pays a quarterly dividend of $0.11 per share. Green Cross Health pays 441.92% of its earnings as a dividend. Fisher & Paykel Healthcare pays out 109.73% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios PRCXF or FSPKF?
Green Cross Health quarterly revenues are --, which are smaller than Fisher & Paykel Healthcare quarterly revenues of --. Green Cross Health's net income of -- is lower than Fisher & Paykel Healthcare's net income of --. Notably, Green Cross Health's price-to-earnings ratio is 13.94x while Fisher & Paykel Healthcare's PE ratio is 62.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Cross Health is 0.32x versus 8.96x for Fisher & Paykel Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCXFGreen Cross Health0.32x 13.94x -- -- FSPKFFisher & Paykel Healthcare8.96x 62.70x -- --
-
Which has Higher Returns PRCXF or PFGTF?
Pacific Edge has a net margin of -- compared to Green Cross Health's net margin of --. Green Cross Health's return on equity of 7.12% beat Pacific Edge's return on equity of -56.46%.
Company Gross Margin Earnings Per Share Invested Capital PRCXFGreen Cross Health-- -- $198.2M PFGTFPacific Edge-- -- $27.9M -
What do Analysts Say About PRCXF or PFGTF?
Green Cross Health has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge has an analysts' consensus of -- which suggests that it could fall by --. Given that Green Cross Health has higher upside potential than Pacific Edge, analysts believe Green Cross Health is more attractive than Pacific Edge.
Company Buy Ratings Hold Ratings Sell Ratings PRCXFGreen Cross Health0 0 0 PFGTFPacific Edge0 0 0 -
Is PRCXF or PFGTF More Risky?
Green Cross Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Pacific Edge has a beta of -2.263, suggesting its less volatile than the S&P 500 by 326.301%.
-
Which is a Better Dividend Stock PRCXF or PFGTF?
Green Cross Health has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Pacific Edge offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Cross Health pays 441.92% of its earnings as a dividend. Pacific Edge pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCXF or PFGTF?
Green Cross Health quarterly revenues are --, which are smaller than Pacific Edge quarterly revenues of --. Green Cross Health's net income of -- is lower than Pacific Edge's net income of --. Notably, Green Cross Health's price-to-earnings ratio is 13.94x while Pacific Edge's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Cross Health is 0.32x versus 4.38x for Pacific Edge. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCXFGreen Cross Health0.32x 13.94x -- -- PFGTFPacific Edge4.38x -- -- --
-
Which has Higher Returns PRCXF or RHCGF?
Ryman Healthcare has a net margin of -- compared to Green Cross Health's net margin of --. Green Cross Health's return on equity of 7.12% beat Ryman Healthcare's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital PRCXFGreen Cross Health-- -- $198.2M RHCGFRyman Healthcare-- -- -- -
What do Analysts Say About PRCXF or RHCGF?
Green Cross Health has a consensus price target of --, signalling downside risk potential of --. On the other hand Ryman Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Green Cross Health has higher upside potential than Ryman Healthcare, analysts believe Green Cross Health is more attractive than Ryman Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings PRCXFGreen Cross Health0 0 0 RHCGFRyman Healthcare0 0 0 -
Is PRCXF or RHCGF More Risky?
Green Cross Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ryman Healthcare has a beta of 0.598, suggesting its less volatile than the S&P 500 by 40.193%.
-
Which is a Better Dividend Stock PRCXF or RHCGF?
Green Cross Health has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Ryman Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Green Cross Health pays 441.92% of its earnings as a dividend. Ryman Healthcare pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios PRCXF or RHCGF?
Green Cross Health quarterly revenues are --, which are smaller than Ryman Healthcare quarterly revenues of --. Green Cross Health's net income of -- is lower than Ryman Healthcare's net income of --. Notably, Green Cross Health's price-to-earnings ratio is 13.94x while Ryman Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Cross Health is 0.32x versus -- for Ryman Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCXFGreen Cross Health0.32x 13.94x -- -- RHCGFRyman Healthcare-- -- -- --
-
Which has Higher Returns PRCXF or SMGRF?
Summerset Group Holdings has a net margin of -- compared to Green Cross Health's net margin of --. Green Cross Health's return on equity of 7.12% beat Summerset Group Holdings's return on equity of 12.83%.
Company Gross Margin Earnings Per Share Invested Capital PRCXFGreen Cross Health-- -- $198.2M SMGRFSummerset Group Holdings-- -- $2.6B -
What do Analysts Say About PRCXF or SMGRF?
Green Cross Health has a consensus price target of --, signalling downside risk potential of --. On the other hand Summerset Group Holdings has an analysts' consensus of -- which suggests that it could fall by --. Given that Green Cross Health has higher upside potential than Summerset Group Holdings, analysts believe Green Cross Health is more attractive than Summerset Group Holdings.
Company Buy Ratings Hold Ratings Sell Ratings PRCXFGreen Cross Health0 0 0 SMGRFSummerset Group Holdings0 0 0 -
Is PRCXF or SMGRF More Risky?
Green Cross Health has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Summerset Group Holdings has a beta of -0.401, suggesting its less volatile than the S&P 500 by 140.118%.
-
Which is a Better Dividend Stock PRCXF or SMGRF?
Green Cross Health has a quarterly dividend of $0.01 per share corresponding to a yield of 0%. Summerset Group Holdings offers a yield of 1.55% to investors and pays a quarterly dividend of $0.08 per share. Green Cross Health pays 441.92% of its earnings as a dividend. Summerset Group Holdings pays out 9.87% of its earnings as a dividend. Summerset Group Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Green Cross Health's is not.
-
Which has Better Financial Ratios PRCXF or SMGRF?
Green Cross Health quarterly revenues are --, which are smaller than Summerset Group Holdings quarterly revenues of --. Green Cross Health's net income of -- is lower than Summerset Group Holdings's net income of --. Notably, Green Cross Health's price-to-earnings ratio is 13.94x while Summerset Group Holdings's PE ratio is 11.05x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Green Cross Health is 0.32x versus 11.74x for Summerset Group Holdings. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income PRCXFGreen Cross Health0.32x 13.94x -- -- SMGRFSummerset Group Holdings11.74x 11.05x -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is Intel Struggling Against AMD?
Due to its disappointing reports, so-so management, and lack of…
Will PayPal Stock Recover or Keep Sliding?
Payments platform behemoth PayPal Holdings, Inc. (NASDAQ:PYPL) is going through…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 34x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.8T
P/E Ratio: 32x
Sell
49
Is NVDA Stock a Buy?
Market Cap: $2.5T
P/E Ratio: 35x
Alerts
Buy
71
PEGA alert for Apr 24
Pegasystems [PEGA] is up 3.13% over the past day.
Buy
67
SMMT alert for Apr 24
Summit Therapeutics [SMMT] is up 10.38% over the past day.
Sell
36
ENPH alert for Apr 24
Enphase Energy [ENPH] is up 1.44% over the past day.
